BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 10379740)

  • 1. Tumor localization and systemic absorption of intravesical instillation of radio-iodinated iododeoxyuridine in patients with bladder cancer.
    Chiou RK; Dalrymple GV; Baranowska-Kortylewicz J; Holdeman KP; Schneiderman MH; Harrison KA; Taylor RJ
    J Urol; 1999 Jul; 162(1):58-62. PubMed ID: 10379740
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tumor uptake and mitotic activity pattern of 5-[125I]iodo-2'- deoxyuridine after intravesical infusion in patients with bladder cancer.
    Mariani G; Collecchi P; Baldassarri S; Di Luca L; Buralli S; Fontanini G; Baranowska-Kortylewicz J; Adelstein SJ; Kassis AI
    J Nucl Med; 1996 Apr; 37(4 Suppl):16S-19S. PubMed ID: 8676197
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tumor-targeting potential of radioiodinated iododeoxyuridine in bladder cancer.
    Van den Abbeele AD; Tutrone RF; Berman RM; Baranowska-Kortylewicz J; Barclay PD; Richie JP; Adelstein SJ; Kassis AI
    J Nucl Med; 1996 Feb; 37(2):315-20. PubMed ID: 8667069
    [TBL] [Abstract][Full Text] [Related]  

  • 4. PET imaging drug distribution after intratumoral injection: the case for (124)I-iododeoxyuridine in malignant gliomas.
    Roelcke U; Hausmann O; Merlo A; Missimer J; Maguire RP; Freitag P; Radü EW; Weinreich R; Gratzl O; Leenders KL
    J Nucl Med; 2002 Nov; 43(11):1444-51. PubMed ID: 12411546
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Radiolabeled iododeoxyuridine: safety evaluation.
    Harrison KA; Dalrymple GV; Baranowska-Kortylewicz J; Holdeman KP; Schneiderman MH; Lieberman RP; Sharp JG; Cohen SM; Leichner PK; Augustine SC; Tempero MA; Taylor RJ; Chiou RK
    J Nucl Med; 1996 Apr; 37(4 Suppl):13S-16S. PubMed ID: 8676196
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pilot clinical trial of 5-[125I]iodo-2'-deoxyuridine in the treatment of colorectal cancer metastatic to the liver.
    Macapinlac HA; Kemeny N; Daghighian F; Finn R; Zhang J; Humm J; Squire O; Larson SM
    J Nucl Med; 1996 Apr; 37(4 Suppl):25S-29S. PubMed ID: 8676200
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The absorption of pirarubicin instilled intravesically immediately after transurethral resection of superficial bladder cancer.
    Yamamoto Y; Nasu Y; Saika T; Akaeda T; Tsushima T; Kumon H
    BJU Int; 2000 Nov; 86(7):802-4. PubMed ID: 11069404
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Systemic absorption and pharmacokinetics of single-dose early intravesical mitomycin C after transurethral resection of non-muscle-invasive bladder cancer.
    Maffezzini M; Campodonico F; Manuputty EE; Puntoni M; Martelli A; Marini V; Tamagno S; Mattioli F
    Urology; 2013 Aug; 82(2):400-4. PubMed ID: 23791221
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Localization of avidin in superficial bladder cancer: a potentially new approach for radionuclide therapy.
    Chinol M; De Cobelli O; Trifirò G; Scardino E; Bartolomei M; Verweij F; Papi S; Matei DV; Paganelli G
    Eur Urol; 2003 Nov; 44(5):556-9. PubMed ID: 14572754
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Clinical investigation on the effect of intravesical instillation of antifibrinolytic agents with bacillus Calmette-Guerin on preventing bladder cancer recurrence].
    Ding GQ; Shen ZJ; Lu J; Jin XD; Chen J; Shi SF
    Zhonghua Wai Ke Za Zhi; 2005 Nov; 43(22):1457-60. PubMed ID: 16318813
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Targeting superficial bladder cancer by the intravesical administration of copper-67-labeled anti-MUC1 mucin monoclonal antibody C595.
    Hughes OD; Bishop MC; Perkins AC; Wastie ML; Denton G; Price MR; Frier M; Denley H; Rutherford R; Schubiger PA
    J Clin Oncol; 2000 Jan; 18(2):363-70. PubMed ID: 10637251
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Serum uptake of doxorubicin intravesically administered soon after transurethral resection of bladder carcinoma].
    Nagakura K; Takao M; Odajima K; Ieda K; Fujioka T; Hayakawa M; Murai M; Nakamura H
    Hinyokika Kiyo; 1989 Sep; 35(9):1509-12. PubMed ID: 2816617
    [TBL] [Abstract][Full Text] [Related]  

  • 13. 5-[123I/125I]iodo-2'-deoxyuridine in metastatic lung cancer: radiopharmaceutical formulation affects targeting.
    Semnani ES; Wang K; Adelstein SJ; Kassis AI
    J Nucl Med; 2005 May; 46(5):800-6. PubMed ID: 15872354
    [TBL] [Abstract][Full Text] [Related]  

  • 14. On the safety of 5-[125I]iodo-2'-deoxyuridine--Preclinical evaluation in swine.
    Baranowska-Kortylewicz J; Dalrymple GV; Harrison KA; Holdeman KP; Sharp JG; Cohen SM; Lieberman RP; Schneiderman MH; Clausen SR; Hoffman D; Lai J; Schneiderman GS; Helseth L
    Acta Oncol; 1996; 35(7):925-33. PubMed ID: 9004773
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of intravenous and intravesical administration of chloro-aluminum sulfonated phthalocyanine for photodynamic treatment in a rat bladder cancer model.
    Bachor R; Flotte TJ; Scholz M; Dretler S; Hasan T
    J Urol; 1992 May; 147(5):1404-10. PubMed ID: 1569696
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacokinetics of intravesical mitomycin C in superficial bladder cancer patients.
    Dalton JT; Wientjes MG; Badalament RA; Drago JR; Au JL
    Cancer Res; 1991 Oct; 51(19):5144-52. PubMed ID: 1913640
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Fundamental studies on intravesical instillation of cis-diamminedichloroplatinum for treatment of urinary bladder tumors. II. On the effects of intravesical instillation of cis-diamminedichloroplatinum in bladder cancer patients].
    Hirao Y; Iwai A; Moriya A; Matsuki H; Yoshida Y; Komada S; Sasaki K; Kubota K; Sanma S; Babaya K
    Hinyokika Kiyo; 1985 Sep; 31(9):1565-73. PubMed ID: 4083214
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Imaging brain tumor proliferative activity with [124I]iododeoxyuridine.
    Blasberg RG; Roelcke U; Weinreich R; Beattie B; von Ammon K; Yonekawa Y; Landolt H; Guenther I; Crompton NE; Vontobel P; Missimer J; Maguire RP; Koziorowski J; Knust EJ; Finn RD; Leenders KL
    Cancer Res; 2000 Feb; 60(3):624-35. PubMed ID: 10676646
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Postoperative prophylactic intravesical instillation of tetrahydropyranyl-adriamycin (THP) for superficial bladder cancer].
    Kanayama H; Yokota K; Kurokawa Y; Kagawa S; Yokozeki H; Inai T; Ogawa I; Akazawa S; Hashimoto H; Mizuta K
    Gan To Kagaku Ryoho; 1999 Apr; 26(5):651-5. PubMed ID: 10234296
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Mechanism of intravesical instillation of pirarubicin for preventing recurrence of non-muscle invasive bladder cancer].
    Li Q; Xu T; Wang XF
    Zhonghua Zhong Liu Za Zhi; 2009 Dec; 31(12):904-7. PubMed ID: 20193328
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.